Compare STEP & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STEP | NVST |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2020 | 2019 |
| Metric | STEP | NVST |
|---|---|---|
| Price | $42.78 | $26.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $71.00 | $26.46 |
| AVG Volume (30 Days) | 1.7M | ★ 2.6M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 0.23 |
| Revenue | $1,993,603,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | N/A | $6.67 |
| Revenue Next Year | $26.41 | $3.55 |
| P/E Ratio | ★ N/A | $112.65 |
| Revenue Growth | ★ 69.69 | N/A |
| 52 Week Low | $38.85 | $18.77 |
| 52 Week High | $77.80 | $30.42 |
| Indicator | STEP | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 55.44 |
| Support Level | $41.11 | $22.31 |
| Resistance Level | $49.24 | $26.63 |
| Average True Range (ATR) | 2.31 | 0.80 |
| MACD | 0.43 | -0.09 |
| Stochastic Oscillator | 54.65 | 45.40 |
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.